arrow
D

Dirk J. Lefeber

Radboud University Medical Center
H指数:54
被引数:1.0万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Diagnosis of Congenital Disorders of Glycosylation Type II Subtypes Through Comprehensive N-Glycan Profiling by Mass Spectrometry

通过质谱法进行全面的N-糖链谱分析诊断II型先天性糖基化障碍亚型

2026-07-230
OA
Aminoadipate-semialdehyde synthase, a potential target for substrate reduction therapy in glutaric aciduria type 1

氨基己二酸半醛合成酶,戊二酸尿症I型的底物减少疗法潜在靶点

2026-03-310
OA
Targeting AASS alleviates neurotoxicity and improves mitochondrial function in astrocyte models for pyridoxine dependent epilepsy

靶向AASS可缓解神经毒性并改善吡哆醇依赖性癫痫星形胶质细胞模型的线粒体功能

2025-09-300
OAAI
Glycoproteomics analysis of complement factor H and its complement-regulatory function during Streptococcus pneumoniae-associated hemolytic uremic syndrome

肺炎链球菌相关溶血尿毒综合征中补体因子H的糖蛋白质组学分析及其补体调节功能

2025-08-210
OA
Imaging flow cytometry-based cellular screening elucidates pathophysiology in individuals with Variants of Uncertain Significance

基于成像流式细胞术的细胞筛选阐明了具有Uncertain Significance Variants个体的病理生理学。

2025-02-071
OA
New treatment for pyridoxine-dependent epilepsy due to ALDH7A1 deficiency: first proof-of-principle of upstream enzyme inhibition in the mouse

由于ALDH7A1缺乏引起的吡哆醇依赖性癫痫的新疗法:小鼠中上游酶抑制的首个原理验证

2025-01-012
OAAI
Genome and RNA sequencing were essential to reveal cryptic intronic variants associated to defective ATP6AP1 mRNA processing

基因组和RNA测序对于揭示与缺陷ATP6AP1 mRNA加工相关的隐性内含子变体至关重要

2024-07-012
PRE
Plasma glycoproteomics delivers high-specificity disease biomarkers by detecting site-specific glycosylation abnormalities

血浆糖蛋白质组学通过检测位点特异性糖基化异常提供高特异性疾病生物标志物

2024-07-015
OAAI
N-linked glycosylation of the M-protein variable region: glycoproteogenomics reveals a new layer of personalized complexity in multiple myeloma

M蛋白可变区的N-连接糖基化: 糖蛋白质组学揭示多发性骨髓瘤中个性化复杂性的新层

2024-02-092
OA